HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Imara Inc. operates as a biopharmaceutical company. The Company develops novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. IMARA serves customers worldwide.
Market Cap | 244.4 Million | Shares Outstanding | 17.407 Million | Avg 30-day Volume | 164.62 Thousand |
P/E Ratio | -2.2 | Dividend Yield | EPS | -6.38 | |
Price/Sales | Price cash flow ratio | Price free cash flow ratio | -8.4 | ||
Book Value | 5.44 | Price to Tangible Book | 2.58 | Alpha | -0.05 |
Short Interest Ratio | % Short Interest to Float | R-squared | 0.197103 | ||
BETA | 3.29794 | 52-week High/Low | 62.71 / 12.9 | Stddev | 0.410842 |
Q3 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 0 | 1 | -100.0% | 0 (0.0%) | 0 (0.0%) | |
Funds Holding: | 32 | 35 | -8.57% | 6 (0.39%) | 8 (0.52%) | -25.0% |
13F shares: | 11.227 Million | 10.935 Million | 2.67% | 3.941 Million | 4.452 Million | -11.48% |
% Ownership | 64.8033 | 63.2782 | 2.41% | 22.75 | 25.7652 | -11.7% |
New Positions: | 2 | 24 | -91.67% | 4 | ||
Increased Positions | 8 | 4 | 100.0% | 2 | ||
Closed Positions | 4 | 6 | -33.33% | 2 | 5 | -60.0% |
Reduced Positions | 16 | 4 | 300.0% | 3 | 3 | 0.0% |
Total Calls | 0 | |||||
Total Puts | 0 | |||||
PUT/CALL Ratio | ||||||
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
6.3 Thousand total shares from 3 transactions
6.3 Thousand total shares from 3 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
BALLAL RAHUL D. CHIEF EXECUTIVE OFFICER |
|
0 | 2020-12-17 | 2 |
GRAY MICHAEL CFO & COO |
|
0 | 2020-12-11 | 1 |
|
0 | 2020-04-22 | 2 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-12-21 16:47:04 -0500 | 2020-12-17 | M | 4,999 | d | 263,999 | direct | ||||||||||
2020-12-21 16:47:04 -0500 | 2020-12-17 | S | 4,999 | $25.00 | d | 0 | direct | yes | -3.9693 | -8.9629 | 0.0 | 1 | -9.7738 | 5 | ||
2020-12-21 16:47:04 -0500 | 2020-12-17 | M | 4,999 | $3.15 | a | 4,999 | direct | -3.9693 | -8.9629 | 0.0 | 1 | -9.7738 | 5 | |||
2020-12-16 16:15:02 -0500 | 2020-12-14 | M | 1 | d | 268,998 | direct | ||||||||||
2020-12-16 16:15:02 -0500 | 2020-12-14 | S | 1 | $25.00 | d | 0 | direct | yes | -0.0838 | -7.7503 | 0.0 | 1 | -7.7503 | 6 | ||
2020-12-16 16:15:02 -0500 | 2020-12-14 | M | 1 | $3.15 | a | 1 | direct | -0.0838 | -7.7503 | 0.0 | 1 | -7.7503 | 6 | |||
2020-12-15 16:26:20 -0500 | 2020-12-11 | M | 1,250 | $4.92 | a | 1,250 | direct | -1.0775 | -6.7551 | 0.0 | 1 | -6.7551 | 6 | |||
2020-12-15 16:26:20 -0500 | 2020-12-11 | M | 1,250 | d | 223,059 | direct | ||||||||||
2020-12-15 16:26:20 -0500 | 2020-12-11 | S | 1,250 | $25.00 | d | 0 | direct | yes | -1.0775 | -6.7551 | 0.0 | 1 | -6.7551 | 6 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |